Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsAdriano Gravina, Federica Perrone, P. Gargiulo et al.|ESMO Open|2025Cited by 8
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analoguesAlessandro Conforti, Carlo Alviggi, Francesco Schettini et al.|The Breast Journal|2019Cited by 7
Ovarian reserve, metabolic and neuroendocrine profiles of cadets from Air Force Academy: a pilot studyAlessandro Conforti, Antonio Mollo, Federica Cariati et al.|Minerva Obstetrics and Gynecology|2024Cited by 3